Literature DB >> 30381788

Comparative De Novo Transcriptome Assembly of Notophthalmus viridescens RNA-seq Data using Two Commercial Software Programs.

Jonathan Chacon1, Math P Cuajungco1,2.   

Abstract

BACKGROUND AND
PURPOSE: The reduction of cost and ease of using core laboratories or commercial sequencing companies have allowed biomedical and health researchers alike to employ reference-based genomic or transcriptomic sequencing (RNA-seq) projects to expand their work. Non-reference based data analysis, in cases of inexperienced researchers, become more challenging despite the availability of many open source and commercial software programs.
METHODS: We performed de novo assembly of RNA-seq data obtained from a non-model organism (Eastern Newt skin) to compare data output of two commercially available software workflows.
RESULTS: Our results show that the software packages performed satisfactorily albeit with differences in how the annotated and novel transcripts were identified and listed.
CONCLUSION: Overall, we conclude that the use of commercial software platforms has a clear advantage to that of open source programs because of convenience with data analysis workflows. One caveat is that users need to know the software's basic algorithm and technical approach, in order to determine the precision and validity of the data output. Thus, it is imperative that researchers fully evaluate the software according to their needs to determine their suitability.

Entities:  

Keywords:  RNA-seq; gene annotation; next generation sequencing; non-model organism

Year:  2018        PMID: 30381788      PMCID: PMC6205749          DOI: 10.32398/cjhp_20181601

Source DB:  PubMed          Journal:  Calif J Health Promot        ISSN: 1545-8717


  8 in total

1.  Re-programming of newt cardiomyocytes is induced by tissue regeneration.

Authors:  Friedemann Laube; Matthias Heister; Christian Scholz; Thilo Borchardt; Thomas Braun
Journal:  J Cell Sci       Date:  2006-10-31       Impact factor: 5.285

2.  RNA-Seq gene expression estimation with read mapping uncertainty.

Authors:  Bo Li; Victor Ruotti; Ron M Stewart; James A Thomson; Colin N Dewey
Journal:  Bioinformatics       Date:  2009-12-18       Impact factor: 6.937

Review 3.  Comparison of next-generation sequencing systems.

Authors:  Lin Liu; Yinhu Li; Siliang Li; Ni Hu; Yimin He; Ray Pong; Danni Lin; Lihua Lu; Maggie Law
Journal:  J Biomed Biotechnol       Date:  2012-07-05

4.  Comparing de novo assemblers for 454 transcriptome data.

Authors:  Sujai Kumar; Mark L Blaxter
Journal:  BMC Genomics       Date:  2010-10-16       Impact factor: 3.969

5.  Newt-omics: a comprehensive repository for omics data from the newt Notophthalmus viridescens.

Authors:  Marc Bruckskotten; Mario Looso; Richard Reinhardt; Thomas Braun; Thilo Borchardt
Journal:  Nucleic Acids Res       Date:  2011-10-27       Impact factor: 16.971

6.  Optimizing de novo transcriptome assembly from short-read RNA-Seq data: a comparative study.

Authors:  Qiong-Yi Zhao; Yi Wang; Yi-Meng Kong; Da Luo; Xuan Li; Pei Hao
Journal:  BMC Bioinformatics       Date:  2011-12-14       Impact factor: 3.169

7.  Comparison of next generation sequencing technologies for transcriptome characterization.

Authors:  P Kerr Wall; Jim Leebens-Mack; André S Chanderbali; Abdelali Barakat; Erik Wolcott; Haiying Liang; Lena Landherr; Lynn P Tomsho; Yi Hu; John E Carlson; Hong Ma; Stephan C Schuster; Douglas E Soltis; Pamela S Soltis; Naomi Altman; Claude W dePamphilis
Journal:  BMC Genomics       Date:  2009-08-01       Impact factor: 3.969

8.  A reference transcriptome and inferred proteome for the salamander Notophthalmus viridescens.

Authors:  Ilgar Abdullayev; Matthew Kirkham; Åsa K Björklund; András Simon; Rickard Sandberg
Journal:  Exp Cell Res       Date:  2013-02-28       Impact factor: 3.905

  8 in total
  1 in total

1.  A transcriptome software comparison for the analyses of treatments expected to give subtle gene expression responses.

Authors:  Cung Nawl Thawng; Geoffrey Battle Smith
Journal:  BMC Genomics       Date:  2022-06-20       Impact factor: 4.547

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.